BiomX to Present at the H.C. Wainwright 26th Annual Global Investment Conference
04 September 2024 - 10:00PM
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a
clinical-stage company advancing novel natural and engineered phage
therapies that target specific pathogenic bacteria, announces today
that Jonathan Solomon, Chief Executive Officer, will present a
corporate overview at the H.C. Wainwright 26th Annual Global
Investment Conference. The conference is being held on September 9
- 11, 2024 at the Lotte New York Palace Hotel.
Presentation Date: |
|
September 9,
2024 |
|
|
|
Time: |
|
Available on-demand starting at 7:00 AM ET |
|
|
|
Webcast Link: |
|
https://journey.ct.events/view/d258dc7c-4d95-483c-9e0e-be6af1e9343d |
A replay of the presentation can be found on the Company’s
website under Events & Presentations and will be available for
90 days: https://ir.biomx.com/news-events
Mr. Solomon will be available for one-on-one meetings throughout
the conference. To request a meeting and to register for the
conference, click
here: https://hcwevents.com/annualconference/
About BiomXBiomX is a clinical-stage company
leading the development of natural and engineered phage cocktails
and personalized phage treatments designed to target and destroy
harmful bacteria for the treatment of chronic diseases with
substantial unmet needs. BiomX discovers and validates proprietary
bacterial targets and applies its BOLT (“BacteriOphage Lead to
Treatment”) platform to customize phage compositions against these
targets. For more information, please visit www.biomx.com, the
content of which does not form a part of this press release.
Contacts:BiomX, Inc.Assaf
Oron+97254-2228901assafo@biomx.com
INVESTORS:CORE IRPeter
Seltzbergpeters@coreir.com
BiomX (AMEX:PHGE)
Historical Stock Chart
From Oct 2024 to Nov 2024
BiomX (AMEX:PHGE)
Historical Stock Chart
From Nov 2023 to Nov 2024